Bridgeway Capital Management’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.5K | Sell |
25,000
-25,000
| -50% | -$9.5K | ﹤0.01% | 1175 |
|
|
2025
Q1 | $52K | Hold |
50,000
| – | – | ﹤0.01% | 1117 |
|
|
2024
Q4 | $48.8K | Buy |
50,000
+25,000
| +100% | +$24.4K | ﹤0.01% | 1158 |
|
|
2024
Q3 | $36.8K | Hold |
25,000
| – | – | ﹤0.01% | 1228 |
|
|
2024
Q2 | $33.8K | Sell |
25,000
-25,000
| -50% | -$33.8K | ﹤0.01% | 1244 |
|
|
2024
Q1 | $82K | Hold |
50,000
| – | – | ﹤0.01% | 1226 |
|
|
2023
Q4 | $96.5K | Hold |
50,000
| – | – | ﹤0.01% | 1246 |
|
|
2023
Q3 | $120K | Hold |
50,000
| – | – | ﹤0.01% | 1194 |
|
|
2023
Q2 | $128K | Hold |
50,000
| – | – | ﹤0.01% | 1218 |
|
|
2023
Q1 | $81.5K | Sell |
50,000
-10,705
| -18% | -$17.4K | ﹤0.01% | 1265 |
|
|
2022
Q4 | $166K | Buy |
60,705
+50,000
| +467% | +$137K | ﹤0.01% | 1131 |
|
|
2022
Q3 | $42K | Sell |
10,705
-8,440
| -44% | -$33.1K | ﹤0.01% | 1361 |
|
|
2022
Q2 | $108K | Sell |
19,145
-4,500
| -19% | -$25.4K | ﹤0.01% | 1212 |
|
|
2022
Q1 | $265K | Buy |
23,645
+2,800
| +13% | +$31.4K | 0.01% | 1115 |
|
|
2021
Q4 | $304K | Sell |
20,845
-5,800
| -22% | -$84.6K | 0.01% | 1100 |
|
|
2021
Q3 | $799K | Buy |
26,645
+23,600
| +775% | +$708K | 0.02% | 887 |
|
|
2021
Q2 | $141K | Hold |
3,045
| – | – | ﹤0.01% | 1294 |
|
|
2021
Q1 | $183K | Hold |
3,045
| – | – | ﹤0.01% | 1291 |
|
|
2020
Q4 | $160K | Buy |
+3,045
| New | +$160K | ﹤0.01% | 1234 |
|